Nándor Makk

Title: Nándor Makk: Innovator in Pharmaceutical Chemistry

Introduction

Nándor Makk is a notable inventor based in Kismaros, Hungary. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit angiogenesis. With a total of 3 patents to his name, Makk's work has the potential to impact cancer treatment and other medical applications.

Latest Patents

Makk's latest patents include innovative compounds designed to inhibit angiogenesis. One of his notable inventions is a series of heterocyclic compounds that can prevent neovascularization in living tissues. These compounds are particularly relevant in the context of tumor growth and metastasis. Another significant patent involves N-([1,4]benzodioxan-2-ylmethyl)-N-(3-chloro-1-propyl)-amine, which possesses α- and β-adrenoceptor antagonistic effects. This compound is useful for treating benign prostate hyperplasia, showcasing Makk's versatility in addressing various medical conditions.

Career Highlights

Throughout his career, Nándor Makk has worked with several prominent companies in the pharmaceutical industry. He has been associated with Gyógyszerkutató Intézet Kft. and Ivax International GmbH. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Makk has collaborated with notable colleagues such as Péter Mátyus and László Hársing. These partnerships have likely enriched his research and development efforts, leading to the successful creation of his patented compounds.

Conclusion

Nándor Makk is a distinguished inventor whose work in pharmaceutical chemistry has the potential to advance medical treatments significantly. His innovative patents reflect his commitment to addressing critical health challenges through scientific research and development.